| TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis |
https://journals.sagepub.com/doi/10.1177/1753466620926800 |
| Drug immunogenicity in patients with inflammatory arthritis and secondary failure to tumour necrosis factor inhibitor therapies: the REASON study |
https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/kex474 |
| Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. Data |
https://www.jmcp.org/doi/full/10.18553/jmcp.2020.26.8.1039 |
| Soluble tumour necrosis factor-alpha receptor improved the function, hypertrophy, and granular sparkling appearance of the left ventricular myocardium in systemic amyloid A amyloidosis: a case report |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319817/ |
| Membranous Nephropathy with Proteinase 3-ANCAassociated Vasculitis Successfully Treated with Rituximab |
https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_4752-20/_article |
| ANCA associated vasculitis |
https://www.ejinme.com/article/S0953-6205(20)30011-X/fulltext |
| Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly |
https://www.karger.com/Article/FullText/509608 |
| Comprehensive health assessment three months after recovery from acute COVID-19 |
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1750/5998118 |